Kyron.bio is revolutionising the way we make our therapeutic drugs. Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective. Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved.
| Website | https://www.kyron.bio/ |
| Employees | 9 (6 on RocketReach) |
| Founded | 2022 |
| Address | 55, Boulevard Vincent Auriol, Paris, Île-de-France 75013, FR |
| Industry | Biotechnology |
| Keywords | Biologics, Drug Development, Protein Engineering, Therapeutic Proteins, Therapeutic Drug Development, Biologic Drugs, Molecular Engineering, Biopharmaceutical, Biotechnology, Pharmaceutical Engineering, Drug Manufacturing, Bioprocessing, Precision Medicine, Pharmaceutical Research, Pharmaceutical Innovation, Advanced Therapeutics, Next Generation Medicine, Medicinal Chemistry, Novel Therapeutics |
| Competitors | Amgen, Invitae, Twist Bioscience, CRISPR Therapeutics, Zymergen, Inc., Sangamo Therapeutics, Inc., Intellia Therapeutics, Inc., Editas Medicine, Sequencing, Geno +48 more (view full list) |
Looking for a particular kyron.bio employee's phone or email?
kyron.bio Questions
Emilia McLaughlin is the Founder of kyron.bio.
6 people are employed at kyron.bio.
kyron.bio is based in Paris, Île-de-France.
Top kyron.bio Employees
-
Emilia McLaughlin
Founder at kyron.bio
Paris, FR1 -
2
-
Damien Toullec
Lab manager at kyron.bio
Paris, FR1 -
1
